Menu
No results found.
603301
Zhende Medical Co., Ltd. – SHA
Weekly Share Price & Valuation Overview
Market Overview
Open
22.1500
Close
23.6600
High
24.4600
Low
22.0100
Trend
0.50031
Zhende Medical Co., Ltd.
China
• SHA - Shanghai Stock Exchange
• 603301
• Currency: CNY
Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment in China. It offers stoma and modern wound care products, surgical infection control products, sensory control protection products, infection control protection products, basic wound care products, and pressure therapy and immobilization products, as well as medical-grade personal care and home health care products. The company sells its products approximately in 70 countries and regions in Europe, North America, Asia, South America, Africa, and Oceania. Zhende Medical Co., Ltd. was founded in 1994 and is headquartered in Shaoxing, China.
Key strengths
- Quick ratio ≥1.0 indicates obligations can be met without inventory.
- Net cash balance sheet provides flexibility for downturns and investment.
Potential weaknesses
- Negative free cash flow — operations may rely on external financing.
Scale & Structure
Core size and share structure. TTM values unless noted. “Estimated” where reconciled from per-share × shares.
- Market Cap Total equity value of the company (share price × shares outstanding).
- CNY 6.31B
- Enterprise Value Operating value: market cap + total debt − cash.
- CNY 6.45B
- Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- CNY 4.29B
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- CNY 1.42B
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- CNY 596.01M
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- CNY 16.04
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- 1.36
- Dividend Yield Annual dividend ÷ share price. Reconciled using dividend per share when available.
- 2.74%
- Shares Outstanding
- 266.45M
- Float Shares
- 104.94M
- Implied Shares Outstanding
- 266.45M
Profitability & Efficiency
TTM basis. “Reconciled” = numerator ÷ TTM revenue. Margins reflect latest TTM calculations.
- Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
7.68%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
13.89%
- Gross Margin (TTM) Reconciled Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
33.04%
- Profit Margin (TTM) Net income ÷ revenue over the last twelve months (reconciled when possible).
-
8.46%
- ROA Return on assets: net income ÷ total assets.
-
2.79%
- ROE Return on equity: net income ÷ shareholder equity.
-
6.41%
Growth
Growth rates are YoY unless labeled QoQ.
- Revenue Growth Year-over-year revenue growth.
-
2.90%
- Earnings Growth (YoY) Year-over-year earnings growth.
-
-32.10%
- Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-
-30.20%
Liquidity & Solvency
Balance-sheet health. Debt metrics shown as latest ratios; D/E is a ratio (not %).
- Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
- 1.34
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 0.18
- Total Cash Cash and equivalents.
- CNY 1.22B
- Total Debt Short + long-term interest-bearing debt.
- CNY 1.10B
- Net Debt Net Cash Total debt − cash (negative = net cash).
- CNY -119.59M
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 1.84
Cash Flow
Shown only when internally consistent; margins are TTM.
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- CNY 407.08M
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- CNY -451.30M
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
9.49%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
-10.52%
- Cash Conversion (OpCF/EBITDA)
- 0.68
Sharemaestro House View
Risk: 3
Sharemaestro internal risk profile (0–3, higher is safer).
Composite Score: 1
Overall internal composite (0–3, higher is better).
Suggested Allocation: 1.67%
Indicative portfolio weighting suggestion based on house view.
Structural Insights
(experimental)
Ownership & Liquidity
Free Float
Proportion of shares available for public trading.
39.4%
Insiders
Shares held by company insiders (officers, directors).
62.6%
Institutions
Shares held by institutions (funds, pensions).
6.0%
Capital Structure
Potential Dilution
Increase in share count if options/convertibles exercise.
None detected
Net Debt
Total debt − cash (negative = net cash).
CNY -119.59M
-2.8% of revenue
Net debt relative to revenue — debt load vs business scale.
Resilience Score
0–100 composite of liquidity, leverage and cash conversion; higher is better. If inputs are unavailable, we estimate using proxies (Net debt vs revenue, Cash-to-Debt). It is a guide, not a rating.
68
Methodology Notes
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
As of: 2025-08-18 10:13
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.
AI generated insights not available yet. Sign in to generate the snapshot.